GSGPX
Price
$10.16
Change
-$0.02 (-0.20%)
Updated
Jun 20 closing price
Net Assets
4.81B
SYMAX
Price
$12.01
Change
-$0.06 (-0.50%)
Updated
Jun 20 closing price
Net Assets
40.63M
Interact to see
Advertisement

GSGPX vs SYMAX

Header iconGSGPX vs SYMAX Comparison
Open Charts GSGPX vs SYMAXBanner chart's image
Goldman Sachs Absolute Ret Trckr P
Price$10.16
Change-$0.02 (-0.20%)
VolumeN/A
Net Assets4.81B
AlphaCentric Symmetry Strategy A
Price$12.01
Change-$0.06 (-0.50%)
VolumeN/A
Net Assets40.63M
GSGPX vs SYMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSGPX vs. SYMAX commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGPX is a Buy and SYMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSGPX has more cash in the bank: 4.81B vs. SYMAX (40.6M). GSGPX pays higher dividends than SYMAX: GSGPX (1.13) vs SYMAX (0.00). GSGPX was incepted earlier than SYMAX: GSGPX (7 years) vs SYMAX (6 years). SYMAX (2.28) is less costly to investors than GSGPX (0.82). SYMAX is a more actively managed with annual turnover of: 299.00 vs. GSGPX (179.00). GSGPX has a lower initial minimum investment than SYMAX: GSGPX (0) vs SYMAX (2500). GSGPX annual gain was more profitable for investors over the last year : 4.11 vs. SYMAX (2.74). SYMAX return over 5 years is better than : 35.60 vs. GSGPX (19.64).
GSGPXSYMAXGSGPX / SYMAX
Total Expense Ratio0.731.9637%
Annual Report Gross Expense Ratio0.822.2836%
Fund Existence7 years6 years-
Gain YTD1.906-2.674-71%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets4.81B40.6M11,847%
Annual Yield % from dividends1.130.00-
Returns for 1 year4.112.74150%
Returns for 3 years21.051.641,286%
Returns for 5 years19.6435.6055%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKBA3.680.12
+3.37%
Akebia Therapeutics
ICLR146.482.90
+2.02%
ICON plc
BCAB0.40N/A
+0.73%
BioAtla
OPAD0.960.01
+0.71%
Offerpad Solutions
SKYW95.22-1.65
-1.70%
SkyWest